loadpatents
name:-0.016817092895508
name:-0.01140284538269
name:-0.00052690505981445
Poyser; Jeffrey Philip Patent Filings

Poyser; Jeffrey Philip

Patent Applications and Registrations

Patent applications and USPTO patent grants for Poyser; Jeffrey Philip.The latest application filed is for "heterocyclic compounds as ccr2b antagonists".

Company Profile
0.9.13
  • Poyser; Jeffrey Philip - Cheshire GB
  • Poyser; Jeffrey Philip - MacClesfield GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Heterocyclic compounds as CCR2B antagonists
Grant 8,710,224 - Bower , et al. April 29, 2
2014-04-29
Heterocyclic Compounds As Ccr2b Antagonists
App 20140038978 - Bower; Justin Fairfield ;   et al.
2014-02-06
Heterocyclic Compounds as CCR2 Antagonists
App 20120264762 - Bower; Justin Fairfield ;   et al.
2012-10-18
Novel Compounds
App 20110152234 - Faull; Alan ;   et al.
2011-06-23
Heterocyclic Compounds as CCR2 Antagonists
App 20110136820 - Bower; Justin Fairfield ;   et al.
2011-06-09
Phenyl thiophene carboxamide compounds as inhibitors of the enzyme IKK-2
Grant 7,956,084 - Faull , et al. June 7, 2
2011-06-07
Piperazine compounds useful as antagonists of C-C chemokines (Ccr2b and CcrS) for the treatment of inflammatory diseases
Grant 7,943,768 - Bower , et al. May 17, 2
2011-05-17
Heterocyclic compounds as ccr2b antagonists
Grant 7,906,645 - Bower , et al. March 15, 2
2011-03-15
Thiophene-carboxamide Derivatives And Their Use As Inhibitors Of The Enzyme Ikk-2
App 20100029754 - Faull; Alan Wellington ;   et al.
2010-02-04
Thiophene Carboxamides As Inhibitors Of The Enzyme Ikk-2
App 20090215829 - Morley; Andrew David ;   et al.
2009-08-27
Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme IKK-2
Grant 7,572,826 - Faull , et al. August 11, 2
2009-08-11
Thiophene carboxamides as inhibitors of the enzyme IKK-2
Grant 7,553,868 - Morley , et al. June 30, 2
2009-06-30
Heterocyclic Compounds as Ccr2b antagonists
App 20090099156 - Bower; Justin Fairfield ;   et al.
2009-04-16
Method of producing an antiangiogenic or vascular permeability reducing effect
Grant 7,498,335 - Hennequin , et al. March 3, 2
2009-03-03
Piperazine Compounds Useful as Antagonists of C-C Chemokines (Ccr2b and Ccr5) for the Treatment of Inflammatory Diseases
App 20080287453 - Bower; Justin Fairfield ;   et al.
2008-11-20
Novel compounds
App 20070015819 - Faull; Alan ;   et al.
2007-01-18
Thiophene carboxanmides as inhibitors of the enzyme ikk-2
App 20060111431 - Morley; Andrew David ;   et al.
2006-05-25
Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
App 20060058522 - Faull; Alan Wellington ;   et al.
2006-03-16
Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases
Grant 7,001,904 - Poyser February 21, 2
2006-02-21
Novel compounds
App 20040242573 - Faull, Alan ;   et al.
2004-12-02
Quinazoline derivatives
Grant 6,806,274 - Crawley , et al. October 19, 2
2004-10-19
Therapy
App 20030225111 - Hennequin, Laurent Francois Andre ;   et al.
2003-12-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed